advertisement

Topcon

Rodríguez-Agirretxe I 11

Showing records 1 to 11 | Display all abstracts from Rodríguez-Agirretxe I

98618 Validation of the SITA faster strategy for the management of glaucoma
Rodríguez-Agirretxe I
International Ophthalmology 2022; 42: 2347-2354
98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Garcia-Medina JJ
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260
98618 Validation of the SITA faster strategy for the management of glaucoma
Loizate E
International Ophthalmology 2022; 42: 2347-2354
98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Benitez-del-Castillo J
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260
98618 Validation of the SITA faster strategy for the management of glaucoma
Astorkiza B
International Ophthalmology 2022; 42: 2347-2354
98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Rodríguez-Agirretxe I
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260
98618 Validation of the SITA faster strategy for the management of glaucoma
Onaindia A
International Ophthalmology 2022; 42: 2347-2354
98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Lopez-Lopez F; Moreno-Valladares A
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260
98618 Validation of the SITA faster strategy for the management of glaucoma
Galdos-Olasagasti L
International Ophthalmology 2022; 42: 2347-2354
98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain

Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260
98618 Validation of the SITA faster strategy for the management of glaucoma
Basasoro A
International Ophthalmology 2022; 42: 2347-2354

Issue 22-4

Change Issue


advertisement

Topcon